BioSpace News Archive

The global liquid handling technology market is forecasted to reach USD 6,323.9 Million by 2027, according to a new report by Reports and Data.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022.

Calyptus Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (“FDA”) granted approval to an Abbreviated New Drug Application (ANDA) for an AP-rated generic version of Cetrotide ® (Cetrorelix Acetate for Injection, 0.25 mg/vial) to Calyptus’ partner - Akorn Operating Company LLC (“Akorn”).

I-Mab today announced that it will report business and corporate updates and financial results for the six months ended June 30, 2022, before the market opens on Tuesday, August 30, 2022.

Accutar Biotechnology, Inc. , a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces that the China National Medical Products Administration (NMPA) has cleared the company’s investigational new drug application (IND) for AC0176 for the treatment of patients with metastatic Castration Resistant Prostate Cancer (mCRPC).

IN8bio, Inc. today announced that the underwriter of its previously announced underwritten public offering of common stock which closed on August 16, 2022 has partially exercised its option to purchase an additional 268,949 shares at the public offering price of $1.90 per share.

The global Consumer Genomics market is forecast to reach USD 6.58 Billion by 2027, according to a new report by Reports and Data.

The medical device testing market is expected to have steady growth during the forecast period 2020-2030.

Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The endometriosis market is likely to experience promising growth across the forecast period of 2021-2031 due to the rising prevalence of chronic diseases around the world.